Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcadia Biosciences (RKDA) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Arcadia Biosciences (RKDA) over the last 12 years, with Q1 2025 value amounting to $750000.0.

  • Arcadia Biosciences' Other Operating Expenses changed N/A to $750000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $750000.0, marking a year-over-year decrease of 8125.0%. This contributed to the annual value of $4.0 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q1 2025, Arcadia Biosciences' Other Operating Expenses is $750000.0.
  • Arcadia Biosciences' 5-year Other Operating Expenses high stood at $4.0 million for Q2 2024, and its period low was -$5.4 million during Q2 2021.
  • Its 5-year average for Other Operating Expenses is -$66777.8, with a median of $58000.0 in 2022.
  • As far as peak fluctuations go, Arcadia Biosciences' Other Operating Expenses plummeted by 10644.38% in 2021, and later surged by 10107.23% in 2022.
  • Quarter analysis of 5 years shows Arcadia Biosciences' Other Operating Expenses stood at -$480000.0 in 2021, then soared by 85.0% to -$72000.0 in 2022, then soared by 126.39% to $19000.0 in 2023, then soared by 20952.63% to $4.0 million in 2024, then tumbled by 81.25% to $750000.0 in 2025.
  • Its last three reported values are $750000.0 in Q1 2025, $4.0 million for Q2 2024, and $19000.0 during Q1 2023.